Add to Watch ListAdd to Watch List Share This PageShare Email This Page Flag This PageFlag

Key People

Management

Judith Abrahams, Vice President, Intellectual Property

Todd Foley joined MPM’s Boston office in 1999 and currently manages the MPM-Novartis BioVentures IV Strategic Fund in addition to investing MPM’s main funds. Prior to MPM, Mr. Foley worked in Business Development at Genentech and management consulting with Arthur D. Little. He holds a B.S. in Chemistry from MIT and an M.B.A. from Harvard Business School.

Board of Directors

Philip B. Simon

No bio available. Add a bio.

Joseph Rubinfeld

No bio available. Add a bio.

Steven B. Fink

From 2000 to 2008, Mr. Fink was the Chief Executive Officer of Lawrence Investments, LLC, a technology and biotechnology private equity investment firm that is controlled by Lawrence J. Ellison. Mr. Fink currently serves as a Vice Chairman of Knowledge Universe (now renamed Krest LLC), a position he has held since 1996. From October 1999 to October 2000, he served as Chief Executive Officer of Nextera Enterprises, Inc., an economic consulting company affiliated with Knowledge Universe. From 1981 to 1986, he served as Chief Executive Officer and Chairman of the board of directors of Anthony Manufacturing Company, a specialty glass and conductive coatings manufacturer.

Mr. Fink serves as Vice Chairman of Heron International, a European real estate development company, and as a director on the board of Spring Group plc, an information technology services company in the United Kingdom and Chairman of the Board of LeapFrog Enterprises, Inc. He also serves on the board of Nobel Learning Communities, Inc., a publicly held non-sectarian, for-profit provider of education and educational services for the pre-elementary through 12th grade market, and as a director of K12 Inc., a publicly held provider of proprietary curriculum and educational services created for online delivery to students in kindergarten through 12th grade. Additionally, Mr. Fink serves on the board of the UCLA Foundation.

Mr. Fink holds a B.S. from the University of California at Los Angeles and a J.D. and an L.L.M. from New York University.

Tomomi Okamoto

No bio available. Add a bio.

Howard T. Slayen

No bio available. Add a bio.

Board of Advisors

Bruce Molitoris

No bio available. Add a bio.

Patrick Murray

No bio available. Add a bio.

Emil Paganini

No bio available. Add a bio.

Lakhmir Chawla

No bio available. Add a bio.

Ravindra L. Mehta

No bio available. Add a bio.

Dganit Dinour

No bio available. Add a bio.

Jayakrishna Ambati

No bio available. Add a bio.

Jason Slakter

No bio available. Add a bio.

Philip J. Rosenfeld

No bio available. Add a bio.

Ayala Pollack

No bio available. Add a bio.

Anat Loewenstein

No bio available. Add a bio.

Dov Weinberger

No bio available. Add a bio.

Peter K. Kaiser

No bio available. Add a bio.

Weekly Newsletter

Signup for the VentureBeat Profiles newsletter to receive top news and hot new startups of the week.

News & Blogs
View All News »

Quark Pharmaceuticals Gets $27M
Apr 8, 2008 - 0 comments

Quark Closes $27 Million Financing
Apr 8, 2008 - 0 comments

Quark Pharmaceuticals on Twitter
Twitter Search »

There are no discussions right now.

Recent Contributors

There are no recent contributors to this company.